- Home
- ONTO vs NBY Comparison
ONTO vs NBY Comparison
Compare ONTO & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONTO
- NBY
- Stock Information
- Founded
- ONTO 1940
- NBY 2000
- Country
- ONTO United States
- NBY United States
- Employees
- ONTO N/A
- NBY N/A
- Industry
- ONTO Industrial Machinery/Components
- NBY
- Sector
- ONTO Industrials
- NBY
- Exchange
- ONTO Nasdaq
- NBY Nasdaq
- Market Cap
- ONTO 4.9B
- NBY 3.4M
- IPO Year
- ONTO N/A
- NBY 2007
- Fundamental
- Price
- ONTO $105.01
- NBY $0.65
- Analyst Decision
- ONTO Strong Buy
- NBY Strong Buy
- Analyst Count
- ONTO 7
- NBY 1
- Target Price
- ONTO $141.67
- NBY $0.85
- AVG Volume (30 Days)
- ONTO 1.2M
- NBY 24.4K
- Earning Date
- ONTO 08-07-2025
- NBY 08-12-2025
- Dividend Yield
- ONTO N/A
- NBY N/A
- EPS Growth
- ONTO 57.20
- NBY N/A
- EPS
- ONTO 4.42
- NBY 0.57
- Revenue
- ONTO $1,025,082,000.00
- NBY $9,781,000.00
- Revenue This Year
- ONTO $3.41
- NBY $23.91
- Revenue Next Year
- ONTO $8.13
- NBY $32.05
- P/E Ratio
- ONTO $23.39
- NBY $1.45
- Revenue Growth
- ONTO 21.23
- NBY 20.52
- 52 Week Low
- ONTO $85.88
- NBY $0.36
- 52 Week High
- ONTO $238.93
- NBY $2.45
- Technical
- Relative Strength Index (RSI)
- ONTO 56.79
- NBY 61.92
- Support Level
- ONTO $98.56
- NBY $0.60
- Resistance Level
- ONTO $104.75
- NBY $0.70
- Average True Range (ATR)
- ONTO 3.60
- NBY 0.03
- MACD
- ONTO 1.08
- NBY 0.01
- Stochastic Oscillator
- ONTO 95.35
- NBY 64.08
About ONTO Onto Innovation Inc.
Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.